177 related articles for article (PubMed ID: 21393996)
1. Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing of CDX1 and EPHB tumor suppressor genes in colorectal cancer.
Rönsch K; Jäger M; Schöpflin A; Danciu M; Lassmann S; Hecht A
Epigenetics; 2011 May; 6(5):610-22. PubMed ID: 21393996
[TBL] [Abstract][Full Text] [Related]
2. DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications.
Jiang X; Tan J; Li J; Kivimäe S; Yang X; Zhuang L; Lee PL; Chan MT; Stanton LW; Liu ET; Cheyette BN; Yu Q
Cancer Cell; 2008 Jun; 13(6):529-41. PubMed ID: 18538736
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress causes epigenetic alteration of CDX1 expression in colorectal cancer cells.
Zhang R; Kang KA; Kim KC; Na SY; Chang WY; Kim GY; Kim HS; Hyun JW
Gene; 2013 Jul; 524(2):214-9. PubMed ID: 23618814
[TBL] [Abstract][Full Text] [Related]
4. Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer.
Jägle S; Rönsch K; Timme S; Andrlová H; Bertrand M; Jäger M; Proske A; Schrempp M; Yousaf A; Michoel T; Zeiser R; Werner M; Lassmann S; Hecht A
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4886-91. PubMed ID: 24707046
[TBL] [Abstract][Full Text] [Related]
5. The Notch-2 gene is regulated by Wnt signaling in cultured colorectal cancer cells.
Ungerbäck J; Elander N; Grünberg J; Sigvardsson M; Söderkvist P
PLoS One; 2011 Mar; 6(3):e17957. PubMed ID: 21437251
[TBL] [Abstract][Full Text] [Related]
6. Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach.
Rau TT; Rogler A; Frischauf M; Jung A; Konturek PC; Dimmler A; Faller G; Sehnert B; El-Rifai W; Hartmann A; Voll RE; Schneider-Stock R
Am J Pathol; 2012 Aug; 181(2):487-98. PubMed ID: 22749770
[TBL] [Abstract][Full Text] [Related]
7. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
[TBL] [Abstract][Full Text] [Related]
8. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
9. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
10. CKIα ablation highlights a critical role for p53 in invasiveness control.
Elyada E; Pribluda A; Goldstein RE; Morgenstern Y; Brachya G; Cojocaru G; Snir-Alkalay I; Burstain I; Haffner-Krausz R; Jung S; Wiener Z; Alitalo K; Oren M; Pikarsky E; Ben-Neriah Y
Nature; 2011 Feb; 470(7334):409-13. PubMed ID: 21331045
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
12. Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer.
Kim HA; Koo BK; Cho JH; Kim YY; Seong J; Chang HJ; Oh YM; Stange DE; Park JG; Hwang D; Kong YY
J Clin Invest; 2012 Sep; 122(9):3248-59. PubMed ID: 22863622
[TBL] [Abstract][Full Text] [Related]
13. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells.
Cortina C; Palomo-Ponce S; Iglesias M; Fernández-Masip JL; Vivancos A; Whissell G; Humà M; Peiró N; Gallego L; Jonkheer S; Davy A; Lloreta J; Sancho E; Batlle E
Nat Genet; 2007 Nov; 39(11):1376-83. PubMed ID: 17906625
[TBL] [Abstract][Full Text] [Related]
14. Wnt2 complements Wnt/β-catenin signaling in colorectal cancer.
Jung YS; Jun S; Lee SH; Sharma A; Park JI
Oncotarget; 2015 Nov; 6(35):37257-68. PubMed ID: 26484565
[TBL] [Abstract][Full Text] [Related]
15. CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.
Pilozzi E; Onelli MR; Ziparo V; Mercantini P; Ruco L
J Pathol; 2004 Nov; 204(3):289-95. PubMed ID: 15378566
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of CDX1 and CDX2 gene expression by deficiency in methyl group donors.
Lu X; Freund JN; Muller M; Ravey J; Nicolas JP; Gueant JL; Namour F
Biochimie; 2008 May; 90(5):697-704. PubMed ID: 18187048
[TBL] [Abstract][Full Text] [Related]
17. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB.
Batlle E; Henderson JT; Beghtel H; van den Born MM; Sancho E; Huls G; Meeldijk J; Robertson J; van de Wetering M; Pawson T; Clevers H
Cell; 2002 Oct; 111(2):251-63. PubMed ID: 12408869
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
[TBL] [Abstract][Full Text] [Related]
19. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
20. EphB/EphrinB receptors and Wnt signaling in colorectal cancer.
Clevers H; Batlle E
Cancer Res; 2006 Jan; 66(1):2-5. PubMed ID: 16397205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
